# WaterStar Capital

WaterStar Capital is a Private Equity based in Beijing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** waterstarcapital.com
- **LinkedIn:** https://www.linkedin.com/company/waterstar-capital-llc

## Regulatory record

- **Reports private funds:** No

## About

WaterStar Capital focuses on investments in life sciences, artificial intelligence, and high-tech industries. The firm has made 4 investments, including a Series A - II investment in Orion Biotechnology on March 15, 2023. WaterStar Capital has 2 portfolio exits, with LumiThera being their most recent exit on July 08, 2025.

## Questions

### What is WaterStar Capital's investment strategy?

WaterStar Capital deploys capital across the full private-to-public lifecycle, participating in early-stage seed and startup rounds, growth equity, and post-IPO PIPE transactions. This multi-stage approach is designed to allow the firm to maintain exposure to portfolio companies as they scale. The strategy concentrates on China's domestic technology and innovation sectors.

### Who runs investment decisions at WaterStar Capital?

WaterStar Capital has not publicly disclosed the names or backgrounds of its investment committee members or managing partners. The firm maintains a low public profile, which is typical of certain Beijing-based private equity firms that raise capital from domestic high-net-worth sources rather than global institutional limited partners.

### Does WaterStar Capital invest only in China?

The firm's investment activity is concentrated in the Greater China region, with a focus on Beijing, Shanghai, and Shenzhen. There is no public evidence of cross-border portfolio exposure, making it effectively a domestic Chinese private equity franchise.

### What investment stages does WaterStar Capital avoid?

Based on its disclosed strategy, the firm does not appear to engage in buyout transactions, distressed debt, or real-asset investing. Its mandate begins at seed and ends at PIPE, leaving large-scale control transactions and hard-asset classes outside of its published scope.

## Related profiles

- [Waterspring Ventures](https://altss.com/profile/waterspring-ventures)
- [Water Street Healthcare Partners](https://altss.com/profile/water-street-healthcare-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/waterstar-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology